A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
Immunotherapy represents an attractive avenue for cancer therapy due to its tumour specificity and relatively low frequency of adverse effects compared to other treatment modalities. Despite many advances being made in the field of cancer immunotherapy, very few immunotherapeutic treatments have bee...
Main Authors: | Carles Puig-Saenz, Joshua R. D. Pearson, Jubini E. Thomas, Stéphanie E. B. McArdle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/8/2100 |
Similar Items
-
Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01) -
Management of triple negative breast cancer in a centenarian
by: Andrew Donaldson, et al.
Published: (2022-09-01) -
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01) -
Progress of Immunotherapy and Its Application in Triple Negative Breast Cancer
by: ZHENG Hongmei, et al.
Published: (2020-11-01) -
Advances in Combined Immunotherapy for Triple Negative Breast Cancer
by: WANG Hua, et al.
Published: (2022-10-01)